ADMA Biologics ADMA Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| ADMA Bio Manufacturing | $493.14M+18.6% | $415.95M+66.5% | $249.88M+73.4% | $144.07M+92.3% | |
| Plasma Collection Centers | $17.03M+62.1% | $10.51M+26.1% | $8.33M-15.5% | $9.87M+68.3% | |
| Nonoperating Income Expense by Business | |||||
| ADMA Bio Manufacturing | -$200K-14.9% | -$174K— | —— | —— | |
| Plasma Collection Centers | -$10K-100% | -$5K— | —— | —— | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest by Business | |||||
| ADMA Bio Manufacturing | 23,507,900,000%+6,025,300,000pp | 17,482,600,000%+12,755,900,000pp | 4,726,700,000%+4,689,300,000pp | 37,400,000%— | |
| Plasma Collection Centers | -536,300,000%-32,200,000pp | -504,100,000%-99,200,000pp | -404,900,000%+1,386,200,000pp | -1,791,100,000%— | |
| Cost Of Revenue by Business | |||||
| ADMA Bio Manufacturing | $199.86M+2.2% | $195.6M+21.4% | $161.16M+48.0% | $108.88M— | |
| Plasma Collection Centers | $17.55M+55.3% | $11.3M+39.2% | $8.12M-18.3% | $9.93M— | |
| Total Assets by Business | |||||
| ADMA Bio Manufacturing | $1.54B+41.3% | $1.09B+10.1% | $992.33M+8.4% | $915.35M+26.5% | |
| Plasma Collection Centers | $112.33M-14.4% | $131.27M-10.5% | $146.67M+2.7% | $142.84M+68.2% | |
| Selling And Marketing Expense by Business | |||||
| ADMA Bio Manufacturing | $26.74M+32.8% | $20.14M+9.4% | $18.41M+34.7% | $13.67M— | |
| Plasma Collection Centers | $0— | $0— | $0— | $0— | |
| Segment Expenditure Addition To Long Lived Assets by Business | |||||
| ADMA Bio Manufacturing | $22.4M+209% | $7.24M+145% | $2.95M— | —— | |
| Plasma Collection Centers | $550K+172% | $202K-88.9% | $1.82M— | —— | |
| General And Administrative Expense by Business | |||||
| Plasma Collection Centers | $0— | $0— | $0— | $0— | |
| Research And Development Expense by Business | |||||
| ADMA Bio Manufacturing | $4.76M+162% | $1.81M-45.0% | $3.3M-8.7% | $3.61M— | |
| Plasma Collection Centers | $0— | $0— | $0— | $0— | |
| Revenue by Geography | |||||
| Non Us | $6.11M-62.6% | $16.31M+22.3% | $13.33M+74.2% | $7.65M-25.8% | |
| US | $504.07M+22.9% | $410.15M+67.5% | $244.88M+67.2% | $146.43M+107% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ADMA Biologics break its business down?
- ADMA Biologics (ADMA) reports business acquisitions pro forma revenue by business across 2 parts — ADMA Bio Manufacturing and Plasma Collection Centers. Each is extracted from the segment footnotes and tracked over time.
- Where does ADMA Biologics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ADMA Biologics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.